Also known as Daytrana
Methylphenidate (Ritalin) is a psychostimulant drug approved for treatment of ADHD or attention-deficit hyperactivity disorder, postural orthostatic tachycardia syndrome and narcolepsy. The original patent was owned by CIBA, now Novartis Corporation. It was first licensed by the FDA in 1955 for treating ADHD, prescribed from 1960, and became heavily prescribed in the 1990s, when the diagnosis of ADHD itself became more widely accepted.Source: Wikipedia
Estimated Total Cost: $41.56 for an average of 28 days supply
Patients are most commonly prescribed methylphenidate to treat attention deficit hyperactivity disorder (adhd), psychotic disorder, developmental disability, and oppositional disorder.
Patients taking methylphenidate most commonly experience side effects like headache, mouth dryness, and nausea.
|Upper abdominal pain|
|Increased heart rate|
|Itching of skin|
|Itching of unknown cause|
|Muscle stiffness or tightness|